Does BEVACIZUMAB-AWWB Cause Malignant neoplasm progression? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Malignant neoplasm progression have been filed in association with BEVACIZUMAB-AWWB. This represents 0.1% of all adverse event reports for BEVACIZUMAB-AWWB.
5
Reports of Malignant neoplasm progression with BEVACIZUMAB-AWWB
0.1%
of all BEVACIZUMAB-AWWB reports
0
Deaths
1
Hospitalizations
How Dangerous Is Malignant neoplasm progression From BEVACIZUMAB-AWWB?
Of the 5 reports, 1 (20.0%) required hospitalization.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BEVACIZUMAB-AWWB. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does BEVACIZUMAB-AWWB Cause?
Off label use (441)
Product storage error (437)
Circumstance or information capable of leading to medication error (346)
Hypertension (187)
Blood pressure increased (163)
Disease progression (160)
Product dose omission issue (158)
Adverse event (143)
Platelet count decreased (118)
Fatigue (104)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which BEVACIZUMAB-AWWB Alternatives Have Lower Malignant neoplasm progression Risk?
BEVACIZUMAB-AWWB vs BEVACIZUMAB-BVZR
BEVACIZUMAB-AWWB vs BEVACIZUMAB-MALY
BEVACIZUMAB-AWWB vs BEXAROTENE
BEVACIZUMAB-AWWB vs BEZAFIBRATE
BEVACIZUMAB-AWWB vs BEZLOTOXUMAB